This issue is part two of a two-part issue involving the emerging field of stem cell transplantation. Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic manipulation of stem cells - Past and future; Gene therapy for ADA deficiency; Haemopoietic stem cell biology; and Indications for BMT.
Cookies are disabled, please note some site features may not function correctly.
We store cookies on your computer when you visit BOOKS etc. to support site features like logging in and remembering your basket items etc. We may also use cookies to better understand how our site is being used so it can be improved.
We allow third parties to store cookies in order to better understand traffic patterns and user habits,
collected statistics are general and do not include personal identity or personal information. Our privacy policy.